Department of Health and Human Services · UII 009-000331763
FDA CDER Regulatory Review Platform
CIO Rating
4 - Moderately Low Risk
FY2025 Funding (PY)
$19.9M
Recompete
Low
Active Contracts
2
Recompete Signal
Recompete Probability: Low
No near-term contract end with BY funding and no sustained CIO trouble.
CIO Rating Trend
4
May '24
4-5 Low Risk3 Medium Risk1-2 High RiskNot Rated
Funding Trend
$12.3M
FY2020
PY$8.6M
FY2021
PY$11.9M
FY2022
PY$13.2M
FY2023
PY$11.5M
FY2024
PY$19.9M
FY2025
PYInternal funding (agency's own budget)Contribution (working-capital / inter-agency)CY = current year · BY = budget year (projected) · PY = prior year
Cost Pool Breakdown
Where the FY2025 spend went, broken down by category.
External Labor
$1.0M
Internal Labor
$825K
Active Contracts
| Prime | PIID | Amount | PoP Start | PoP End |
|---|---|---|---|---|
| — | 75F40121A00008 | — | — | — |
| — | 75F40122F19004 | — | — | — |
Get the AI Pursuit Report for "FDA CDER Regulatory Review Platform"
Strategic interpretation, personalized fit score (NAICS + certs + past performance), incumbent analysis, and win-themes recommendations. ~6-8 page PDF, generated in 30 seconds.
$49 per report
Or included in Pro ($799/mo, 25 reports/month) and Enterprise (unlimited)